Verena Walter

1.2k total citations
11 papers, 928 citations indexed

About

Verena Walter is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology. According to data from OpenAlex, Verena Walter has authored 11 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Public Health, Environmental and Occupational Health, 2 papers in Epidemiology and 2 papers in Pharmacology. Recurrent topics in Verena Walter's work include Malaria Research and Control (4 papers), Mosquito-borne diseases and control (3 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Verena Walter is often cited by papers focused on Malaria Research and Control (4 papers), Mosquito-borne diseases and control (3 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Verena Walter collaborates with scholars based in Switzerland, United States and Germany. Verena Walter's co-authors include Campbell P. Howard, Tom Thurén, Paul M. Ridker, Johannes Hensen, Giulia Renda, Peter Libby, Jacques Lestage, Rose-Marie Bluthé, S. Poole and Robert Dantzer and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Verena Walter

11 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verena Walter Switzerland 8 271 269 223 142 136 11 928
Robert Pyle United States 11 310 1.1× 425 1.6× 474 2.1× 37 0.3× 128 0.9× 13 2.0k
F.J. Laso Spain 22 309 1.1× 262 1.0× 503 2.3× 43 0.3× 51 0.4× 49 1.3k
Jennifer E. Cole United Kingdom 19 657 2.4× 358 1.3× 227 1.0× 35 0.2× 99 0.7× 29 1.3k
Imre Földesi Hungary 16 70 0.3× 147 0.5× 112 0.5× 44 0.3× 133 1.0× 66 695
Arsun Bektas United States 12 234 0.9× 263 1.0× 134 0.6× 38 0.3× 98 0.7× 15 942
Toni Karhu Finland 20 171 0.6× 202 0.8× 163 0.7× 104 0.7× 136 1.0× 29 1.1k
Orli R. Etingin United States 10 163 0.6× 142 0.5× 135 0.6× 61 0.4× 231 1.7× 13 929
Margitta T. Kampman Norway 25 461 1.7× 136 0.5× 173 0.8× 102 0.7× 31 0.2× 41 1.7k
Halina Bartosik-Psujek Poland 21 260 1.0× 271 1.0× 159 0.7× 67 0.5× 30 0.2× 116 1.3k
Priya Prakash United States 14 316 1.2× 324 1.2× 199 0.9× 40 0.3× 72 0.5× 37 1.1k

Countries citing papers authored by Verena Walter

Since Specialization
Citations

This map shows the geographic impact of Verena Walter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Walter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Walter more than expected).

Fields of papers citing papers by Verena Walter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Walter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Walter. The network helps show where Verena Walter may publish in the future.

Co-authorship network of co-authors of Verena Walter

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Walter. A scholar is included among the top collaborators of Verena Walter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Walter. Verena Walter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Clift, Paul, Felix Berger, Lars Søndergaard, et al.. (2024). Efficacy and safety of macitentan in Fontan-palliated patients: 52-week randomized, placebo-controlled RUBATO Phase 3 trial and open-label extension. Journal of Thoracic and Cardiovascular Surgery. 169(2). 385–394.e5. 2 indexed citations
2.
Hensen, J., Campbell P. Howard, Verena Walter, & Tom Thurén. (2013). Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: Results of secondary endpoints from a randomized, placebo-controlled trial. Diabetes & Metabolism. 39(6). 524–531. 91 indexed citations
3.
Ridker, Paul M., Campbell P. Howard, Verena Walter, et al.. (2012). Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen. Circulation. 126(23). 2739–2748. 430 indexed citations
4.
Carrasquilla, Gabriel, Edwin M. Monsell, Marc Cousin, et al.. (2012). Randomized, Prospective, Three-Arm Study to Confirm the Auditory Safety and Efficacy of Artemether-Lumefantrine in Colombian Patients with Uncomplicated Plasmodium falciparum Malaria. American Journal of Tropical Medicine and Hygiene. 86(1). 75–83. 20 indexed citations
5.
Ridker, Paul M., Campbell P. Howard, Verena Walter, & Tom Thurén. (2012). EFFECTS OF INTERLEUKIN-1β INHIBITION WITH CANAKINUMAB ON IL-6, FIBRINOGEN, AND HSCRP: A RANDOMIZED PLACEBO CONTROLLED TRIAL. Journal of the American College of Cardiology. 59(13). E1539–E1539. 3 indexed citations
6.
Bassat, Quique, Raquel González, Sónia Machevo, et al.. (2011). Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges. Malaria Journal. 10(1). 369–369. 13 indexed citations
7.
Makanga, Michael, Quique Bassat, Catherine O. Falade, et al.. (2011). Efficacy and Safety of Artemether-Lumefantrine in the Treatment of Acute, Uncomplicated Plasmodium falciparum Malaria: A Pooled Analysis. American Journal of Tropical Medicine and Hygiene. 85(5). 793–804. 46 indexed citations
8.
Manyando, Christine, Moses Sinkala, Evans Mpabalwani, et al.. (2010). Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia. Malaria Journal. 9(1). 249–249. 53 indexed citations
9.
10.
Bluthé, Rose-Marie, J.L. Bret-Dibat, Sophie Layé, et al.. (1994). Cytokines induce sickness behaviour by a vagal mediated mechanism. Journal of Neuroimmunology. 54(1-2). 160–160. 5 indexed citations
11.
Bluthé, Rose-Marie, Verena Walter, Patricia Parnet, et al.. (1994). Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism.. PubMed. 317(6). 499–503. 222 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Pyle Breakdown of academic impact, for papers by F.J. Laso Breakdown of academic impact, for papers by Jennifer E. Cole Breakdown of academic impact, for papers by Imre Földesi Breakdown of academic impact, for papers by Arsun Bektas Breakdown of academic impact, for papers by Toni Karhu Breakdown of academic impact, for papers by Orli R. Etingin Breakdown of academic impact, for papers by Margitta T. Kampman Breakdown of academic impact, for papers by Halina Bartosik-Psujek Breakdown of academic impact, for papers by Priya Prakash
Rankless by CCL
2026